← Back to Search

Brachytherapy

Ultrasound-Guided Prostate Brachytherapy for Prostate Cancer

N/A

Recruiting

Research Sponsored by Western University, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard of care

Male, aged 18 years or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month following data collection

Awards & highlights

Study Summary

This trial is testing a new ultrasound method to help guide prostate cancer surgery.

Who is the study for?

This trial is for men aged 18 or older who have been diagnosed with prostate cancer and are suitable and consenting to high-dose-rate brachytherapy as standard care. Participants must be willing to provide written consent. Men who have had previous radiotherapy to the prostate cannot participate.Check my eligibility

What is being tested?

The study tests a new method of visualizing the placement of brachytherapy needles in the prostate using power Doppler ultrasound, which may enhance needle localization by making vibrations visible when an oscillator contacts the needle during treatment.See study design

What are the potential side effects?

Since this trial focuses on improving visualization techniques during standard brachytherapy without introducing new drugs, side effects are likely similar to those of regular brachytherapy, such as discomfort at the needle insertion site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I agree to undergo high-dose-rate brachytherapy as part of my treatment.

Select...

I am a man aged 18 or older.

Select...

My prostate cancer was confirmed through a biopsy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month following data collection

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month following data collection

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month following data collection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Needle Trajectory

Trial Design

1Treatment groups

Experimental Treatment

Group I: PatientExperimental Treatment1 Intervention

Patient undergoing standard care prostate high dose rate brachytherapy.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor

239 Previous Clinical Trials

56,901 Total Patients Enrolled

1 Trials studying Prostate Cancer

45 Patients Enrolled for Prostate Cancer

Media Library

Prostate Brachytherapy (Brachytherapy) Clinical Trial Eligibility Overview. Trial Name: NCT03861507 — N/A

Prostate Cancer Research Study Groups: Patient

Prostate Cancer Clinical Trial 2023: Prostate Brachytherapy Highlights & Side Effects. Trial Name: NCT03861507 — N/A

Prostate Brachytherapy (Brachytherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03861507 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any enrollees currently being sought for this clinical investigation?

"Absolutely. Clinicaltrials.gov hosts information that confirms the recruitment status of this trial, which was initially posted on March 4th 2020 and last revised on August 8th 2022. This research seeks to enroll 20 people from a single location."

Answered by AI

To what extent is this research endeavor recruiting participants?

"Affirmative. Clinicaltrials.gov indicates that the trial, which was first announced on March 4th 2020 is still recruiting patients. The aim is to enroll 20 people at a single medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound

Aaron Fenster 2020. "Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03861507.

All > Canada Prostate Cancer